In a recent study published in Jama Network, researchers investigated the impact of coronavirus disease 2019 (COVID-19) on biomarkers in the cerebrospinal fluid (CSF). Study: Viral Antigen and ...
Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Cerebrospinal fluid (CSF) inflammatory marker levels were found to be associated with ...
Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 Effective diagnosis, prognostication, ...
News-Medical.Net on MSN
Sleep loss triggers brain fluid pulses that impair attention, study finds
By Hugo Francisco de Souza New neuroimaging research shows that when sleep-deprived people lose focus, the brain briefly ...
The world’s first AI-based optical diagnostic platform offers potential for near-instant diagnosis of CSF rhinorrhea.
Medical Device Network on MSN
Pharaoh Neuro raises $20m, picks ex-Medtronic exec for CEO role
Pharaoh Neuro’s cerebrospinal fluid management system has already demonstrated positive prospective trial results.
- The two-arm Phase 2a study is expected to enroll 20 first-recurrent GBM patients to receive VBI’s cancer vaccine candidate, VBI-1901, in combination with either GM-CSF or AS01 B - Initial ...
Understanding Barriers and Facilitators to High-Quality Cancer Care Among Veterans With Lung Cancer: A Qualitative Study We conducted a cluster-randomized trial among 32 oncology clinics from the NCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results